Exelixis Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (35)

Latest Posts

About This Stock More About This Stock
E Boris Bounce; Trump Tripwire
Article By: Vivian Lewis
Sunday, December 15, 2019 5:30 PM EST
Boris Johnson beat the pollsters handily and Britain went into holiday mode. Meanwhile back on Capitol Hill, the on-again-off-again trade deal with China was on again on. The drug price limits bill is dead in the water which will boost pharma stocks.
In this article: BLRX, LLY, RHHBY, EXEL, GSK, BVNRY, CZZ, IRL, MXE, NOK, SLB, MXCHF, NPSNY, TCEHY, HOLI, AQN, PROSY
Read
The 5 Top Biotech Stocks To Buy For 2020
Article By: Money Morning
Thursday, October 31, 2019 6:25 AM EST
As an investor, it pays to know who benefits the most from our elected officials. In 2019, that has been particularly true for biotech stocks.
In this article: JAZZ, LGND, EXEL, INVA, VNDA
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EST
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
Profiting From Changes In Stock Personality
Article By: Marc Gerstein
Wednesday, November 28, 2018 11:32 PM EST
Do stocks have personalities? Yes, they do, and we all know it even though we may not explicitly use that language when we think or talk about stocks.
In this article: ALEX, BK, CPF, NLS, PBI, PHM, TPC, SGA, TREE, EXEL, EGBN, GOGO, HRTG, HY Also: WMT, TSLA, SPY
Read
Trump Announces Plan To Reign In Drug Prices And Pharma Stocks Rally
Article By: Zacks Investment Research
Sunday, May 13, 2018 11:37 AM EST
President Trump unveiled his plan to control US drug prices. Stock prices of the biggest drug companies briefly declined, only to reverse course and ended the day broadly higher. The reason? The plan doesn’t seem to be “taking them on” at all.
In this article: LLY, MRK, AMGN, EXEL, ABBV
Read

PARTNER HEADLINES

Latest Tweets for $EXEL

No tweets yet!